{"id":"NCT04244084","sponsor":"Materia Medica Holding","briefTitle":"Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection","officialTitle":"Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of MMH-407 in the Treatment of Acute Respiratory Viral Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-08","primaryCompletion":"2020-04-09","completion":"2020-04-09","firstPosted":"2020-01-28","resultsPosted":"2021-10-06","lastUpdate":"2022-05-17"},"enrollment":240,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Viral Respiratory Infection"],"interventions":[{"type":"DRUG","name":"MMH-407","otherNames":["Raphamin"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"MMH-407","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the efficacy and safety of ММН-407 in treatment of acute respiratory viral infection (ARVI).","primaryOutcome":{"measure":"Time to Resolution of Acute Respiratory Viral Infection (ARVI) Symptoms","timeFrame":"14 days of observation.","effectByArm":[{"arm":"MMH-407","deltaMin":4.1,"sd":1.9},{"arm":"Placebo","deltaMin":5,"sd":2.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0155"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":26,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":118},"commonTop":["Epigastric pain","Purulent bronchitis","Herpes simplex","Diarrhea","Dry mouth"]}}